Navigation Links
Testosterone in Medical Technology
... prescribed for a reversible reduction
of serum testosterone to the level of castration in adult men suffering ... and safety profile. Triptorelin
decreased serum testosterone to the level of castration in all patients.
Concurrent with the decrease in testosterone levels, the treatment reduced
deviant sexual ...
... prescribed for a reversible reduction of serum testosterone to the level of castration in adult men suffering ... and safety profile. Triptorelin decreased serum testosterone to the level of castration in all patients. Concurrent with the decrease in testosterone levels, the treatment reduced deviant sexual ...
... New Data Highlights the Need for testosterone Screening in At-Risk ... with Tostran(R), a topical, metered dose 2% testosterone gel, significantly improves insulin sensitivity ... regulatory authorities later this year. The testosterone replacement In hypogonadal men with either ...
... study, BPH was induced in rats through subcutaneous injection of testosterone propionate (TP). One week after initiation of BPH, either D-3263, ... is a known inhibitor of 5-alpha reductase, the enzyme that converts testosterone to DHT, D-3263 is not an inhibitor of this enzyme suggesting that the two ...
... treatment. Hormone therapy slows the tumor growth by stopping or blocking testosterone from entering the cancer cells. Prostate cancer cells are typically dependent on testosterone or other androgens as growth factors. Thus, although initially effective, ...
... treatment. Hormone therapy slows the tumor growth by stopping or blocking testosterone from entering the cancer cells. Prostate cancer cells are typically dependent on testosterone or other androgens as growth factors. Thus, although initially effective, ...
... results showed that 97.5% of patients achieved castrate levels of serum testosterone 28 days after the first injection and that 93% of the patients maintained serum testosterone levels below castrate level (defined as < 1.735 nmol/L or 50 ng/dL) from ...
... hair loss) for women of non-childbearing age only, and the anti-androgens spironolactone and flutamide that work by blocking the male hormone testosterone at the cellular level of the hair follicle. These oral medications also may be an option for women who may not want to spend time applying minoxidil ...
... developing and marketing to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical ...
... is a synthetic hormone known as a luteinizing hormone releasing hormone (LHRH) agonist, which suppresses the production of testosterone in the testicles. The growth of the prostate is regulated in part by the level and activity of testosterone. TRELSTAR(R) is available in a 4-week ...
... Meeting in Orlando, Fla., on Wednesday, May 21, 2008, at 2:50 PM ET. In a preclinical study, BPH was induced through subcutaneous injection of testosterone propionate (TP). One week prior to initiation of testosterone, either D-3263 or finasteride, a current treatment for BPH, was administered daily for ...
... infection, which has already completed two Phase 3 trials. Our other clinical stage product candidate, Opterone(R), is a topically applied SEPA-based testosterone cream designed to treat male hypogonadism. Our pipeline of clinical-stage and early-stage product candidates is based on our SEPA, MacroDerm(TM) and ...
... inhibits infertility by utilizing a non-steroidal hormonal therapy known as a selective androgen receptor modulator. "Past clinical studies using testosterone for male contraception were not effective at preventing pregnancy without producing significant negative side- effects," said James Dalton, Ph.D., ...
... onychomycosis, a condition commonly known as nail fungus. Our other clinical stage product candidate, Opterone(R), is a topically applied SEPA-based testosterone cream designed to treat male hypogonadism. In addition to EcoNail and Opterone, our pipeline of early-stage product candidates is based on our SEPA, ...
... first and only dual 5ARI for the treatment of enlarged prostate, inhibits both the type I and type II isoenzymes responsible for the conversion of testosterone into dihydrotestosterone (DHT). DHT is the primary male hormone responsible for the enlargement of the prostate. AVODART provides the power to ...
... children or adolescents. The effects in these populations are unknown. Avoid taking ROZEREM with alcohol. ROZEREM has been associated with decreased testosterone levels and increased prolactin levels. Health professionals should be mindful of any unexplained symptoms possibly associated with such changes in ...
... of hypogonadal men after switching brands of testosterone replacement gel therapy. Total ... at , records of 370 hypogonadal men on once-daily testosterone gel replacement therapy (Testim or AndroGel) were ... or patient preference. "Patients using testosterone replacement gel therapy sometimes will fail to ...
... at month three who showed morning total serum testosterone concentrations within the normal ... in the 12.5mg and 25mg treatment arms with total testosterone in the physiological range at month three ... 0.0001). At month three, the mean improvement in testosterone levels was 184.3 and 259.2 ng/dl for both the ...
... other program in late clinical development, is designed to restore normal testosterone production by the testes and is being tested in a non-pivotal U.S. Phase 3 clinical trial for the treatment of testosterone deficiency in men due to secondary hypogonadism. For more information, ...
... program in late clinical development, is designed to restore normal testosterone production by the testes in men and has recently completed a six-month U.S. non-pivotal Phase 3 clinical trial for the treatment of testosterone deficiency due to secondary hypogonadism. According to industry sources, ...
... Pharmaceuticals, Inc., BioSante's licensee, and LibiGel(R) (transdermal testosterone gel) in Phase III development by BioSante for the treatment of female sexual dysfunction (FSD). Also in development is Bio-T-Gel(TM), a testosterone gel for male hypogonadism, and an oral contraceptive using BioSante ...
... prescribed for a reversible reduction of serum testosterone to the level of castration in adult men suffering ... and safety profile. Triptorelin decreased serum testosterone to the level of castration in all patients. Concurrent with the decrease in testosterone levels, the treatment reduced deviant sexual ...
Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
... in combining the rapid, sustained suppression of testosterone that degarelix offers in this treatment. IADT ... levels of testosterone.(1)(2) Suppression of testosterone to castrate levels occurred significantly faster ... group achieved a 90 percent decrease in median testosterone levels compared with the leuprolide group, which ...FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
... intramuscular injection, an investigational testosterone preparation for the treatment of male ... NEBIDO is a novel, long-acting injectable testosterone preparation for the treatment of male ... NEBIDO is expected to be the first long-acting testosterone preparation available in the U.S. in the growing ...... New Data Highlights the Need for testosterone Screening in At-Risk ... with Tostran(R), a topical, metered dose 2% testosterone gel, significantly improves insulin sensitivity ... regulatory authorities later this year. The testosterone replacement In hypogonadal men with either ...
New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
... obese men are at an increased risk of having low testosterone levels, so these new findings provide ... body of evidence surrounding the benefits of testosterone therapy for those who are hypogonadal, men are ... they are experiencing can be attributed to low testosterone and, therefore, are left undiagnosed and ...Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
... Hutchinson Center. The researchers found that testosterone levels were four times higher in metastatic ... which disrupt the conversion of progesterone to testosterone precursors, as well as inhibitors of enzymes that perform subsequent steps in testosterone production: AKR1C3 and 17BHSD3. For the study, ...Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
... 94 Percent of Men Maintained Normal testosterone Levels Throughout ... in the Phase III study had previously used other testosterone treatments. "An estimated four to five million ... of Urology at Harvard Medical School. "Low testosterone is associated with other significant health ...Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
... undecanoate), a long-acting injectable testosterone therapy under development for the treatment of ... demonstrated a rapid achievement of steady state testosterone levels, minimal excursions outside of the normal ... of patients maintaining a eugonadal (normal) testosterone range. NEBIDO met its primary endpoints, a ...Testosterone May Improve Mental Function, From the Harvard Men's Health Watch
... mental processes. However, research suggests that testosterone levels may affect men's cognitive performance, ... cognitive impairment and dementia in others. testosterone levels decline with age, just when memory begins ... found some connections. For instance, higher testosterone levels in midlife have been linked to better ...Indevus Announces Submission of New Drug Application
... intramuscular injection, a long-acting testosterone therapy intended to treat male patients with ... of NEBIDO in over 75 countries to date. The U.S. testosterone therapy market is currently estimated to be ... pharmacokinetic guidelines for the approval of testosterone therapy products for male hypogonadism. The trial ...Methadone Frequently Causes Menopausal Symptoms in Young Women
... -- Methadone medication frequently depresses estradiol, progesterone and testosterone hormone levels to menopausal levels, even in women less than thirty years ... old, who we detoxed from methadone arrived with estradiol, progesterone or testosterone hormone levels, in the post menopausal range." A 1975 University ...... study, BPH was induced in rats through subcutaneous injection of testosterone propionate (TP). One week after initiation of BPH, either D-3263, ... is a known inhibitor of 5-alpha reductase, the enzyme that converts testosterone to DHT, D-3263 is not an inhibitor of this enzyme suggesting that the two ...
... treatment. Hormone therapy slows the tumor growth by stopping or blocking testosterone from entering the cancer cells. Prostate cancer cells are typically dependent on testosterone or other androgens as growth factors. Thus, although initially effective, ...
... treatment. Hormone therapy slows the tumor growth by stopping or blocking testosterone from entering the cancer cells. Prostate cancer cells are typically dependent on testosterone or other androgens as growth factors. Thus, although initially effective, ...
... results showed that 97.5% of patients achieved castrate levels of serum testosterone 28 days after the first injection and that 93% of the patients maintained serum testosterone levels below castrate level (defined as < 1.735 nmol/L or 50 ng/dL) from ...
Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
... lining that can contribute to sexual dysfunction in women. For males, testosterone levels and the cavernosal arteries of the penis are affected, eroding ... improve by one to two years after treatment, but that methods such as testosterone replacement, erectile-function medications, and other adaptive strategies ...... hair loss) for women of non-childbearing age only, and the anti-androgens spironolactone and flutamide that work by blocking the male hormone testosterone at the cellular level of the hair follicle. These oral medications also may be an option for women who may not want to spend time applying minoxidil ...
Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
... substance triptorelin, a gonadotropin releasing hormone (GnRH) agonist analogue. The product will be prescribed for the reversible reduction of serum testosterone to the level of castration in order to lower sexual drive in adult men suffering from sexual deviations. "This is a great accomplishment for ...Neurocrine Biosciences Presents Elagolix Data
... information on changes in prostate size, weight, hormone levels and cell immunohistochemistry. The data reveal that transient inhibition of plasma testosterone and intra-prostatic androgens results in the reduction of prostate weight, a reduction in epithelial proliferation and suppression of prostate ....BIOCOM's 4th Annual DeviceFest Honors Companies
... diseases and disorders associated with aging, including insulin resistance, diabetes, neuropathy, cardiovascular disease, Alzheimer's and declining testosterone levels. Flexiciser received the "Life Changing" award for its device designed to improve movement to individuals who are unable to maintain the ...... developing and marketing to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical ...
Prostate Cancer Treatment Offers Results Without Side Effects
... dysfunction), incontinence (urine leakage) or a host of other side effects. He went on a raw food diet, had his dental amalgams removed and took testosterone blockers, which also eliminated his libido. He joined a clinical trial, but his cancer began to spread and he lost an alarming amount of weight. ...... is a synthetic hormone known as a luteinizing hormone releasing hormone (LHRH) agonist, which suppresses the production of testosterone in the testicles. The growth of the prostate is regulated in part by the level and activity of testosterone. TRELSTAR(R) is available in a 4-week ...
... Meeting in Orlando, Fla., on Wednesday, May 21, 2008, at 2:50 PM ET. In a preclinical study, BPH was induced through subcutaneous injection of testosterone propionate (TP). One week prior to initiation of testosterone, either D-3263 or finasteride, a current treatment for BPH, was administered daily for ...
... infection, which has already completed two Phase 3 trials. Our other clinical stage product candidate, Opterone(R), is a topically applied SEPA-based testosterone cream designed to treat male hypogonadism. Our pipeline of clinical-stage and early-stage product candidates is based on our SEPA, MacroDerm(TM) and ...
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
... of triptorelin 6-month formulation in 120 patients with advanced prostate cancer, showed that 97.5% of patients achieved castrate levels of serum testosterone 28 days after the first injection and that 93% of the patients maintained serum testosterone levels below castrate level (defined as < or equal to ...... inhibits infertility by utilizing a non-steroidal hormonal therapy known as a selective androgen receptor modulator. "Past clinical studies using testosterone for male contraception were not effective at preventing pregnancy without producing significant negative side- effects," said James Dalton, Ph.D., ...
... onychomycosis, a condition commonly known as nail fungus. Our other clinical stage product candidate, Opterone(R), is a topically applied SEPA-based testosterone cream designed to treat male hypogonadism. In addition to EcoNail and Opterone, our pipeline of early-stage product candidates is based on our SEPA, ...
... first and only dual 5ARI for the treatment of enlarged prostate, inhibits both the type I and type II isoenzymes responsible for the conversion of testosterone into dihydrotestosterone (DHT). DHT is the primary male hormone responsible for the enlargement of the prostate. AVODART provides the power to ...
... children or adolescents. The effects in these populations are unknown. Avoid taking ROZEREM with alcohol. ROZEREM has been associated with decreased testosterone levels and increased prolactin levels. Health professionals should be mindful of any unexplained symptoms possibly associated with such changes in ...
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
... developing and marketing to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical ...... of hypogonadal men after switching brands of testosterone replacement gel therapy. Total ... at , records of 370 hypogonadal men on once-daily testosterone gel replacement therapy (Testim or AndroGel) were ... or patient preference. "Patients using testosterone replacement gel therapy sometimes will fail to ...
... at month three who showed morning total serum testosterone concentrations within the normal ... in the 12.5mg and 25mg treatment arms with total testosterone in the physiological range at month three ... 0.0001). At month three, the mean improvement in testosterone levels was 184.3 and 259.2 ng/dl for both the ...
Indevus Reports Positive Data From Phase III NEBIDO Trial
... a long- acting injectable testosterone therapy under development for the treatment of ... pharmacokinetic guidelines for the approval of testosterone therapy products for male hypogonadism. The ... and an outlier analysis (based on the maximum testosterone concentrations during the steady state dosing ...New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
... believe their male partner's symptoms of low testosterone negatively impact their relationship, treatment ... of the relationship. Low testosterone, or testosterone deficiency associated with hypogonadism, is a ... gland that inhibits hormone secretion and testosterone production in men. As many as five million men ...... other program in late clinical development, is designed to restore normal testosterone production by the testes and is being tested in a non-pivotal U.S. Phase 3 clinical trial for the treatment of testosterone deficiency in men due to secondary hypogonadism. For more information, ...
... program in late clinical development, is designed to restore normal testosterone production by the testes in men and has recently completed a six-month U.S. non-pivotal Phase 3 clinical trial for the treatment of testosterone deficiency due to secondary hypogonadism. According to industry sources, ...
... Pharmaceuticals, Inc., BioSante's licensee, and LibiGel(R) (transdermal testosterone gel) in Phase III development by BioSante for the treatment of female sexual dysfunction (FSD). Also in development is Bio-T-Gel(TM), a testosterone gel for male hypogonadism, and an oral contraceptive using BioSante ...
Other ContentsOther TagsOther Tags
(Date:5/23/2013)... School of Public Health at Emory University, along ... have received a $4 million grant over four ... University (Health and Exposome Research Center: Understanding Lifetime ... grant awarded in the United States. , ... Institute of Environmental Health Sciences (NIEHS) of the ...
(Date:5/23/2013)... undergo surgery or harsh treatments because science fails ... forms of the disease. Researchers at Case Western ... developing technology that allows patients to safely choose ... or take drastic measures. , The project is ... of biomedical engineering at Case Western Reserve and ...
(Date:5/23/2013)... Frontiers, one of the world,s largest and fastest ... new journal, Frontiers in Bioengineering and Biotechnology ... all specialties, Frontiers in Bioengineering and Biotechnology ... diverse and emerging bioengineering and biotechnology research to ... in Bioengineering and Biotechnology will provide an ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3Frontiers launches new open-access journal in Bioengineering and Biotechnology 2(Date:5/24/2013)... 24 (HealthDay News) -- People with high levels of ... die of liver disease than those with lower levels, ... cadmium in urine is evidence of long-term exposure to ... and tobacco smoke, the Johns Hopkins researchers explained. ... cadmium directly causes liver disease but instead suggest an ...
(Date:5/24/2013)... Seattle, WA (PRWEB) May 24, 2013 ... consider when picking out a home security monitoring ... comparisons help make 6Webs.com the useful resource consumers prefer ... recently completed performing their evaluations of the leading wireless ... home security companies are rated on a number of ...
(Date:5/24/2013)... 2013 According to a May 15, 2013 ... Leads to Spikes in Plastic Surgery Requests,” a ... prevalence of facial plastic surgery and cosmetic improvements ... become keenly aware of the need to look good online ... Google and even Skype's video chat feature (Go to goo.gl/WO0PR). ...
(Date:5/24/2013)... LONG BEACH, CA (PRWEB) May 24, 2013 ... California's health care education community, proudly participated in festivities ... on April 19-21. The event provided the perfect backdrop ... and facilities at 236 E. 3rd Street, housed in ... the Arts Building. , ACC was an active exhibitor ...
(Date:5/24/2013)... May 24 (HealthDay News) -- The number of ... after spending time in an emergency room has ... research. The study, conducted by researchers at ... and Health Services in Washington, D.C., found that ... on average before being admitted to the ICU. ...
Breaking Medicine News(10 mins):Health News:High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study 2Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2[0] High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study[0] 2013 Best Wireless Security System Providers Reported by 6Webs.com[0] Facebook and Google – Is Social Media Driving Demand for Plastic Surgery?[0] American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach[0] Sharp Rise in ICU Admissions From U.S. Emergency Rooms
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |